Alprostadil

Prostaglandin and its intermediate

Bulk order in 1kg/bag, 5kg/bag,as per request.

Molecule modification on clients’ request (gram to kilos scale).

Contact Us

Product Details
Product Name
Alprostadil
CAS
745-65-3
Purity
Not less than 99%
Package
in 25kg/drum, 1kg/bag, as per request.
Synonyms
alprostadil|Prostaglandin E1|745-65-3|PGE1|Edex|Caverject|Muse|Prostin VR|Befar|Alprostadilum|Femprox|Topiglan|Alprox-TD|Liprostin|Prostandin|l-Prostaglandin E1|Vitaros|Prink|Prostin VR Pediatric|PGE-1|Prostavasin|Lipoprost|Promostan|Prostivas|Caverject Impulse|l-PGE1|PGE1alpha|(11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid|(-)-Protaglandin E1|(13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate|11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid|7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid|U-10136|DTXSID9022578|UNII-F5TD010360|Alprostadil(Caverject)|CHEBI:15544|ONO 1608|ONO-1608|EINECS 212-017-2|CHEMBL495|Alprostadilum [INN-Latin]|F5TD010360|NSC 165559|NSC-165559|U-10,136|AI3-62116|DTXCID502578|Vasaprostan|(13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid|9-oxo-11R,15S-dihydroxy-13E-prostaenoic acid|U 10136|MFCD00077860|7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid|Alprostadil [USAN:USP:INN:BAN:JAN]|Minprog|Sugiran|Viridal|(-)-Prostaglandin E1|3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid|l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid|Alprostadilum (INN-Latin)|Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-|(1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid|ALPROSTADIL (MART.)|ALPROSTADIL [MART.]|ALPROSTADIL (USP-RS)|ALPROSTADIL [USP-RS]|(13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoate|ALPROSTADIL (USP IMPURITY)|ALPROSTADIL [USP IMPURITY]|Alista|ALPROSTADIL (USP MONOGRAPH)|ALPROSTADIL [USP MONOGRAPH]|FemLife|ProstaglandinE1|RayVa|Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)-|Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l-|Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11a,13E,15S)-|7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid|7-[(1r,3r)-3-Hydroxy-2-[(1e,3s)-3-Hydroxyoct-1-En-1-Yl]-5-Oxocyclopentyl]heptanoic Acid|Alprostadil (USAN:USP:INN:BAN:JAN)|SMR000112594|Lipo-PGE1|Befar (TN)|Prink (TN)|Prostaglandin E1alpha|Edex (TN)|Muse (TN)|SR-01000597593|MR-256|Prostin VR pediatric (TN)|Alprostadil Prostoglandin E1|BML1-F06|NSC165559|Alprostadil(usan)|(1R,2R,3R)-3-Hydroxy-2-[(E)-(3S)-3-hydroxy-1-octenyl]-5-oxocyclopentaneheptanoic acid|HEI-507|NCGC00016535-01|7-((1R,2R,3R)-3-Hydroxy-2-((1E,3S)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid|7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]heptanoic acid|Alprostadil; 7-[(1R,2R,3R)-3-Hydroxy-2-[(1E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid|CAS-745-65-3|XPG|11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid|PGE1;Prostaglandin E1|Prestwick2_001018|Prestwick3_001018|ALPROSTADIL [INN]|ALPROSTADIL [JAN]|PROSTINVR PEDIATRIC|ALPROSTADIL [USAN]|ALPROSTADIL [VANDF]|PGE1 (Prostaglandin E1)|SCHEMBL33317|ALPROSTADIL [WHO-DD]|BSPBio_001175|BSPBio_001488|MLS000758964|MLS001424250|BIDD:GT0747|PROSTAGLANDIN E1 [MI]|BPBio1_001293|GTPL1882|Alprostadil (JP17/USP/INN)|ALPROSTADIL [ORANGE BOOK]|C01EA01|G04BE01|PGE1, Prostaglandin E1, powder|HMS1361K10|HMS1571K17|HMS1791K10|HMS1989K10|HMS2052L11|HMS2090L08|HMS2098K17|HMS3268I09|HMS3402K10|HMS3414N09|HMS3648O17|HMS3678N07|HMS3715K17|(11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid|AMY30076|BCP01740|EX-A1411|HY-B0131|Tox21_110482|3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid|BDBM50101853|LMFA03010134|s1508|AKOS015961103|Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11.alpha.,13E,15S)-|AC-6095|BCP9000277|CCG-101188|CS-1905|DB00770|NC00438|IDI1_033958|Prostaglandin E1, >=99.0% (TLC)|SMP2_000271|NCGC00016535-19|NCGC00025234-02|NCGC00025234-03|NCGC00025234-04|NCGC00025234-05|AS-16360|Prostaglandin E1, PGE1, 745-65-3|Alprostadil 100 microg/mL in Acetonitrile|Muse (intraurethral alprostadil suppository)|11,15-Dihydroxy-9-oxoprost-13-en-1-oate|AB00514004|NS00009541|P1917|Alprostadil, meets USP testing specifications|C04741|C76381|D00180|Prostaglandin E1, >=98% (HPLC), synthetic|AB00514004-06|AB00514004-08|AB00514004_09|11,15-Dihydroxy-9-oxoprost-13-en-1-oic acidl|A838163|EN300-22411483|Q579348|SR-01000946253|SR-01000597593-1|SR-01000597593-5|SR-01000597593-6|SR-01000946253-1|W-104416|BRD-K52459643-001-06-0|BRD-K52459643-001-10-2|BRD-K52459643-001-17-7|(13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoate|(13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoic acid|Alprostadil, European Pharmacopoeia (EP) Reference Standard|(13e)-(15s)-11alpha,15-dihydroxy-9-oxoprost-13-enoic acid|(13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoic acid|11,15-dihydroxy-9-oxoprost-13-en-1-oic acid (ACD/Name 4.0)|3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate|Alprostadil, United States Pharmacopeia (USP) Reference Standard|(+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate|(+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid|(-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate|(-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid|(11alpha,12alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid|Prostaglandin E1, synthetic, powder, BioReagent, suitable for cell culture|Prostaglandin E1, powder, gamma-irradiated, BioXtra, suitable for cell culture
Keywords